MARKET

PACB

PACB

Pacific Biosc
NASDAQ
2.255
-0.175
-7.20%
After Hours: 2.290 +0.035 +1.55% 19:59 11/06 EST
OPEN
2.430
PREV CLOSE
2.430
HIGH
2.540
LOW
2.240
VOLUME
9.56M
TURNOVER
--
52 WEEK HIGH
3.435
52 WEEK LOW
1.070
MARKET CAP
705.65M
P/E (TTM)
-5.2885
1D
5D
1M
3M
1Y
5Y
1D
Pacific Biosciences Q3: Another Revenue Guidance Cut
Seeking Alpha · 2d ago
Analysts Offer Insights on Healthcare Companies: Pacific Biosciences (PACB), Seres Therapeutics (MCRB) and Relay Therapeutics (RLAY)
TipRanks · 3d ago
Pacific Biosciences Is Maintained at Underweight by Barclays
Dow Jones · 3d ago
Pacific Biosciences Price Target Raised to $2.00/Share From $1.25 by Barclays
Dow Jones · 3d ago
Barclays Maintains Underweight on Pacific Biosciences, Raises Price Target to $2
Benzinga · 3d ago
Pacific Biosciences Price Target Raised to $3.00/Share From $2.00 by Piper Sandler
Dow Jones · 3d ago
Piper Sandler Reiterates Neutral on Pacific Biosciences, Raises Price Target to $3
Benzinga · 3d ago
PacBio (PACB) Q3 2026 Earnings Call Transcript
The Motley Fool · 3d ago
More
About PACB
Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops, and manufactures sequencing solutions. Its products and technology include HiFi long-read sequencing technology, which addresses a set of applications including human germline sequencing, plant and animal sciences, infectious disease, microbiology, oncology, and other applications. Its sequencing technology supports oncology research by enabling analysis of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), providing researchers with insight into cancer biology. It focuses on creating sequencing systems to provide customers with a view of genomes, transcriptomes, and epigenomes. Its customers include academic and governmental research institutions, commercial testing and service laboratories, genome centers, public health labs, hospitals and clinical research institutes, contract research organizations (CROs), pharmaceutical companies, and agricultural companies.

Webull offers Pacific Biosciences of California Inc stock information, including NASDAQ: PACB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PACB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PACB stock methods without spending real money on the virtual paper trading platform.